5XH-17618-61063
4 vaccinations
5 coded responses
34 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 454 / OH
- Registered
- 2021-03-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-12
Dose 1 — Pfizer-BioNTech
-
2021-03-05
Dose 2 — Pfizer-BioNTech
-
2021-03-11
Registered in v-safe
-
2021-03-11
Survey response — days 1–6 daily, dose 2MedDRA: Erythema, Rash, Swelling — Feeling: Good · Site: Swelling · Rash, not including the immediate area around the injection siteFree text: The swelling, redness, and rash peaked at about 48 hours. Max redness and induration approximately 7 cmMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-12
Survey response — day 7, dose 2MedDRA: Injection site induration, Papule — Feeling: Good · Site: Swelling · Rash, not including the immediate area around the injection siteFree text: 3 papules fading chest and antecubital which appeared about day 1-- 2nd shot. Induration from day 1--2nd shot down to 2-3 cm induration. No redness and pain on palpation now gone. 2MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-06-04
- 2021-09-05
-
2021-10-01
Dose 3 — Pfizer-BioNTech
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Feeling cold, Injection site erythema, Pain, Pain in extremity, Syncope, Tenderness — Feeling: Fair · Site: Pain, Swelling · Muscle or body achesFree text: Felt cold, arm sore to move and touch with pink at site faint. Cold when sitting.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-03
Survey response — days 1–6 daily, dose 3MedDRA: Chills, Pyrexia, Swelling — Feeling: Poor · Headache, Muscle or body aches · Be unable to do your normal daily activitiesFree text: Chilled and feverish just after report day prior completed. Abated a few hours before this report. Swelling much less than after dose 2.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-04
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-17
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-11-12
- 2021-12-31
- 2022-04-01
-
2022-04-13
Dose 4 — Moderna
-
2022-04-18
Survey response — days 1–6 daily, dose 4MedDRA: Swelling, Tenderness — Feeling: GoodFree text: Slight tenderness and swelling for about 2-3 daysMedDRA releases: 2024-11 · check-in free text available
- 2022-04-19
- 2022-04-20
- 2022-04-27
- 2022-05-04
- 2022-05-11
- 2022-05-18
- 2022-05-25
- 2022-07-13
- 2022-10-12
- 2023-04-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-12 | Pfizer-BioNTech | |
| 2 | 2021-03-05 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
| 4 | 2022-04-13 | Moderna | No |
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): The swelling, redness, and rash peaked at about 48 hours. Max redness and induration approximately 7 cm
Release 5 — day 7, dose 2
Systemic reaction (other): 3 papules fading chest and antecubital which appeared about day 1-- 2nd shot. Induration from day 1--2nd shot down to 2-3 cm induration. No redness and pain on palpation now gone. 2
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Felt cold, arm sore to move and touch with pink at site faint. Cold when sitting.
Systemic reaction (other): Chilled and feverish just after report day prior completed. Abated a few hours before this report. Swelling much less than after dose 2.
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Slight tenderness and swelling for about 2-3 days
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Chills | · | · | ✓ |
| SRO | Erythema | ✓ | ✓ | ✓ |
| SRO | Feeling cold | · | · | ✓ |
| SRO | Injection site erythema | · | · | ✓ |
| SRO | Injection site induration | ✓ | ✓ | ✓ |
| SRO | Pain | · | · | ✓ |
| SRO | Pain in extremity | · | · | ✓ |
| SRO | Papule | ✓ | ✓ | ✓ |
| SRO | Pyrexia | · | · | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
| SRO | Swelling | ✓ | ✓ | ✓ |
| SRO | Syncope | · | · | ✓ |
| SRO | Tenderness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release